On Friday, the FDA will host its long-awaited public hearing on CBD.
Last year, GW Pharmaceuticals got its CBD drug Epidiolex approved as a pharmaceutical treatment for severe pediatric seizure disorders.
- However, the agency has struggled with how to regulate less specialized CBD products like infused food and drinks.
- It has warned several CBD companies not to make unproven health claims about their products, but denies it has a policy of “enforcement discretion.“
Natural Products Insider - Stat News has a good explainer.
- Former FDA Commissioner Dr. Scott Gottlieb, who arranged for the meeting, said evidence of CBD’s medicinal value is lacking.
Stat
CBD companies continue to struggle with accepting payments. But the processor Square is launching a test program for some CBD brands, by invite only.
The Outline, Forbes (Tom Angell)
Quick Hit
- A new study found CBD may reduce cravings and anxiety in heroin users.
NBC - Canadian company Aurora said it has inked a multi-million dollar deal with UFC to study CBD on athlete recovery and wellness.
MarketWatch - A field test popular with police can’t tell the difference between THC and CBD.
NBC - The California state senate passed a bill to allow veterinarians to prescribe CBD.
KTLA
